期刊文献+

青年人中的成年发病型糖尿病13型1例报道 被引量:2

A case report of maturity-onset diabetes of the young13
原文传递
导出
摘要 目的探讨青年人中的成年发病型糖尿病13型(MODY13)的临床表现、诊断方法及治疗方案。方法完善1例MODY13患者入院后的相关检查,同时行全外显子组检测。结果全外显子组检测结果显示,患者内向整流钾离子通道J家族11因子(KCNJ11)存在变异,调整治疗方案为服用格列美脲能有效改善糖尿病症状。结论MODY13患者的诊断需借助基因检测,确诊后根据患者年龄使用药物治疗并对饮食进行调控,能够有效控制血糖。 Objective To investigate the clinical manifestations,diagnosis and treatment of maturity-onset diabetes of the young13(MODY13).Methods One patient with MODY13 was examined after admission,and whole exome test was performed.Results Whole exome test showed that there was a mutation in potassium channel,inwardly rectifying subfamily J,member 11(KCNJ11).The treatment plan was adjusted.After glimepiride was administered,symptoms of diabetes were effectively improved.Conclusion The diagnosis of MODY13 requires genetic testing.After confirmation,medication and diet should be adjusted according to patients?age to control blood glucose.
作者 李林童 侯新国 秦君 梁凯 任建民 LI Lintong;HOU Xinguo;QIN Jun;LIANG Kai;REN Jianmin(Department of Endocrinology,Qilu Hospital of Shandong University,Jinan 250012,Shandong,China)
出处 《山东大学学报(医学版)》 CAS 北大核心 2020年第6期71-75,96,共6页 Journal of Shandong University:Health Sciences
关键词 青年人中的成年发病型糖尿病13型 特殊类型糖尿病 内向整流钾离子通道J家族11因子 糖尿病 全外显子组检测 磺脲类药物 Maturity-onset diabetes of the young13 Special type of diabetes Potassium channel,inwardly rectifying subfamily J,member 11 Diabetes Whole exome test Sulfonylureas
  • 相关文献

参考文献4

二级参考文献41

  • 1Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 andneonatal diabetes: new clinical syndromes, new scientific in- sights, and new therapy [ J ]. Diabetes, 2005,54: 2503-2513.
  • 2Rariq M, Flanagan SE, Patch AM, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SURI) mutation J].Diahetes Care, 2008, 31: 204-209.
  • 3Pearson ER, Flechtner I, Njlstad PR, et al. Switching from insu- lin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations [ J]. N Engl J Med, 2006,355 : 467-477.
  • 4Stcy J, Greeley SA, Paz VP. Diagnosis and treatment of neonatal diabetes : a United States experience [ J ]. Pediatr Diabetes, 2008, 9 : 450-459.
  • 5Proks P, Girard C, Haider S, et al. A gating mutation at the inter- nal mouth of the Kir6.2 pore is associated with DEND syn- drome [ J ] .EMBO Rep, 2005,6 (5) : 470-475.
  • 6Polak M, Car 6 H. Neonatal diabetes meUitus : a disease linked to multiple mechanisms [ J ]. Orphanet J Rare Dis, 2007,9: 2" 12.
  • 7Stanik J, Gasperikova D, Paskova M, et al. Prevalence of perma- nent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJII and ABCC$ muta- tion carriers [J ].J C lin Endocrinol Metab, 2007,92:1276-1282.
  • 8Suzuki S, Makita Y, Mukai T. Molecular basis of neonatal diabe- tes in Japanese patients [J l- J Clin Endocrinol Metab, 2007,92: 3979-3985.
  • 9Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K channels [J]. Prog Biophys Mol Biol, 2003,81 (2) : 133-176.
  • 10Shimomura K. The KATP channel and neonatal diabetes [J]. Endocr J,2009,56(2) : 165-175.

共引文献15

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部